Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alterity Therapeutics (ATHE) Other Non-Current Assets (2016)

Alterity Therapeutics has reported Other Non-Current Assets over the past 2 years, most recently at $32998.0 for Q4 2016.

  • For Q4 2016, Other Non-Current Assets rose 0.85% year-over-year to $32998.0; the TTM value through Dec 2016 reached $32998.0, up 0.85%, while the annual FY2016 figure was $32845.9, 7.07% down from the prior year.
  • Other Non-Current Assets for Q4 2016 was $32998.0 at Alterity Therapeutics, roughly flat from $32845.9 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $35343.2 in Q2 2015 and troughed at $32718.6 in Q4 2015.